ロード中...
PD-Loma: a cancer entity with a shared sensitivity to the PD-1/PD-L1 pathway blockade
Clinical trials have now identified over 30 cancer histotypes with sensitivity to anti-PD-(L)1 therapies. It is the first time in oncology that a class of drugs has demonstrated such a wide spectrum of activity in monotherapy. This subgroup of cancers (‘PD-Lomas’) is driving the clinical research st...
保存先:
| 出版年: | Br J Cancer |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6325162/ https://ncbi.nlm.nih.gov/pubmed/30413824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0294-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|